The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis

OBJECTIVE: To investigate the efficacy and safety of angiogenesis inhibitors in the treatment of recurrent ovarian cancer (OC). METHODS: Electronic databases including PubMed, Web of Science, and the Cochrane Library were searched to find eligible studies until August 10, 2021. The data on overall s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunmei, Zhao, Wancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396859/
https://www.ncbi.nlm.nih.gov/pubmed/35996165
http://dx.doi.org/10.1186/s13048-022-01028-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396859/
https://www.ncbi.nlm.nih.gov/pubmed/35996165
http://dx.doi.org/10.1186/s13048-022-01028-7

Ejemplares similares